BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
88 results:

  • 1. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
    Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
    JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deciphering the Mechanism of Siwu Decoction Inhibiting liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation.
    Chu X; Xie F; Hou C; Zhang X; Wang S; Xie H; An C; Li Y; Zhao L; Xue P; Zhu S
    Integr Cancer Ther; 2024; 23():15347354241236205. PubMed ID: 38462929
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NOP2-mediated m5C methylation of xpd is associated with hepatocellular carcinoma progression.
    Sun GF; Ding H
    Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation.
    Zuo TT; Zhu J; Gao F; Wang JS; Song QH; Wang HY; Sun L; Zhang WQ; Kong DJ; Guo YS; Yang JB; Wei F; Wang Q; Jin HY; Ma SC
    Environ Int; 2023 May; 175():107933. PubMed ID: 37088008
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gene variations related to the hepatocellular carcinoma: Results from a field synopsis and Bayesian revaluation.
    Penha Mesquita A; Victor Oliveira Monteiro A; Luiz Araújo Bentes Leal A; Dos Santos Pessoa L; de Siqueira Amorim Júnior J; Rogério Souza Monteiro J; Andrade de Sousa A; Fernando Pereira Vasconcelos D; Carolina Alves de Oliveira A; Leão Pereira A; Rodolfo Pereira da Silva F
    Gene; 2023 Jun; 869():147392. PubMed ID: 36966980
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.
    Brown TJ; Mamtani R; Gimotty PA; Karasic TB; Yang YX
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2345-2354. PubMed ID: 36862158
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer.
    Hjorth CF; Damkier P; Stage TB; Feddersen S; Hamilton-Dutoit S; Ejlertsen B; Lash TL; Bøggild H; Sørensen HT; Cronin-Fenton D
    Cancer Chemother Pharmacol; 2023 Feb; 91(2):157-165. PubMed ID: 36598552
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
    Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
    Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic liver cancer Stage C Patients: A National Study.
    Chen CT; Hsu CH; Cheng AL; Shao YY
    Anticancer Res; 2022 Sep; 42(9):4461-4470. PubMed ID: 36039431
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus.
    Kumada T; Toyoda H; Yasuda S; Ito T; Tsuji K; Fujioka S; Hiraoka A; Kariyama K; Nouso K; Ishikawa T; Tamai T; Tada T; Tanaka J
    J Viral Hepat; 2022 Oct; 29(10):919-929. PubMed ID: 35790055
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Preoperative Alpha-Fetoprotein and Radiological Total Tumor Diameter as Predictors of Hepatocellular Carcinoma Recurrence After liver Transplantation.
    Galdino-Vasconcelos MR; Feijó MS; Ferro HM; Gomes ACR; De Almeida Santos ME; Ferreira G; Jorge F; Trevizoli N; Diaz LG; De Campos PB; Cajá G; Ullmann R; Figueira AV; Morato T; Watanabe ALC
    Transplant Proc; 2022 Jun; 54(5):1333-1340. PubMed ID: 35768294
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study.
    Liu T; Zhang Q; Song C; Siyin ST; Chen S; Zhang Q; Song M; Cao L; Shi H
    Int J Cancer; 2022 Jul; 151(2):297-307. PubMed ID: 35368093
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
    Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V
    Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments.
    Li S; Li H; Yin D; Xue X; Chen X; Li X; Li J; Yi Y
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):25. PubMed ID: 35090330
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metronidazole-Induced Hepatitis in a Teenager With Xeroderma Pigmentosum and Trichothiodystrophy Overlap.
    Abiona A; Cordeiro N; Fawcett H; Tamura D; Khan SG; DiGiovanna JJ; Lehmann AR; Fassihi H
    Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34593652
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Replication of Oncology Randomized Trial Results using Swedish Registry Real World-Data: A Feasibility Study.
    Jemielita T; Widman L; Fox C; Salomonsson S; Liaw KL; Pettersson A
    Clin Pharmacol Ther; 2021 Dec; 110(6):1613-1621. PubMed ID: 34549809
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Mechanism of Xiaoyao San in treatment of depression,breast hyperplasia,and functional dyspepsia based on network pharmacology].
    Wei FX; Liu HL; Fan YH; Li XQ; Zhao SJ; Qin XM; Liu XJ
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4230-4237. PubMed ID: 34467737
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.
    Elsayed M; Wagstaff W; Behbahani K; Villalobos A; Bercu Z; Majdalany BS; Akce M; Schuster DM; Mao H; Kokabi N
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):1937-1944. PubMed ID: 34312687
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility.
    Zhuo Z; Miao L; Hua W; Chen H; Yang Z; Li Y; Zhang J; Li S; Cheng J; Li L; Xia H; He J
    Int J Cancer; 2021 Nov; 149(9):1649-1658. PubMed ID: 34196959
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.
    He Y; Tao W; Shang C; Qi C; Ji D; Lu W; Chen G
    Int J Exp Pathol; 2021 Jun; 102(3):157-162. PubMed ID: 33993564
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.